Stuedal Anne, Gram Inger Torhild, Bremnes Yngve, Adlercreutz Herman, Veierød Marit B, Ursin Giske
Department of Nutrition, University of Oslo, Norway.
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2154-9. doi: 10.1158/1055-9965.EPI-05-0116.
Certain phytoestrogens, such as lignans, may protect against developing breast cancer. Enterolactone is a lignan metabolite produced by the intestinal flora from dietary precursors such as whole grains, vegetables, and fruits. Enterolactone has been shown to have weak estrogenic and antiestrogenic properties. We decided to examine the association between plasma levels of enterolactone and mammographic density, a biomarker for breast cancer risk.
We included data from postmenopausal women ages 55 and older who participated in a cross-sectional mammogram study in Tromsø, Norway. Mammograms, plasma enterolactone measurements, as well as information on anthropometric and hormonal/reproduction factors were available on 616 women. We assessed mammographic density using a previously validated computer-assisted method. We estimated correlation coefficients and conducted multiple regression analyses.
Mean mammographic density increased slightly across quartiles of enterolactone; the women in the highest quartile had, on average, 3.1% (absolute difference) higher percentage mammographic density compared with the lowest quartile (P(trend) < 0.01). After adjustment for age, body mass index, number of full-term pregnancies, age at first birth, and use of postmenopausal hormone therapy, the mean difference in density was reduced to 2.0% (P(trend) = 0.05). Results were similar when restricted to the 454 current hormone nonusers. The fully adjusted statistical model explained 28.3% of the total variability in mammographic percentage density, with body mass index contributing 18.2% and enterolactone only 0.9%.
In our study, higher levels of enterolactone were associated with slightly higher percentage mammographic density. Our results suggest that if higher enterolactone levels reduce the risk of developing breast cancer in postmenopausal women, then this effect is not through lowering mammographic density.
某些植物雌激素,如木脂素,可能预防乳腺癌的发生。肠内酯是肠道菌群由全谷物、蔬菜和水果等膳食前体产生的木脂素代谢产物。已表明肠内酯具有弱雌激素和抗雌激素特性。我们决定研究血浆肠内酯水平与乳腺X线密度之间的关联,乳腺X线密度是乳腺癌风险的生物标志物。
我们纳入了挪威特罗姆瑟参加横断面乳腺X线检查研究的55岁及以上绝经后女性的数据。616名女性有乳腺X线照片、血浆肠内酯测量值以及人体测量和激素/生殖因素方面的信息。我们使用先前验证的计算机辅助方法评估乳腺X线密度。我们估计相关系数并进行多元回归分析。
随着肠内酯四分位数的增加,平均乳腺X线密度略有增加;最高四分位数的女性与最低四分位数相比,平均乳腺X线密度百分比高3.1%(绝对差异)(P趋势<0.01)。在调整年龄、体重指数、足月妊娠次数、初产年龄和绝经后激素治疗使用情况后,密度平均差异降至2.0%(P趋势=0.05)。当仅限于454名当前未使用激素的女性时,结果相似。完全调整后的统计模型解释了乳腺X线密度百分比总变异性的28.3%,其中体重指数贡献了18.2%,肠内酯仅贡献了0.9%。
在我们的研究中,较高水平的肠内酯与略高的乳腺X线密度百分比相关。我们的结果表明,如果较高的肠内酯水平降低绝经后女性患乳腺癌的风险,那么这种作用不是通过降低乳腺X线密度来实现的。